107 related articles for article (PubMed ID: 9258062)
1. Update on the appropriate staging evaluation for newly diagnosed prostate cancer.
O'Dowd GJ; Veltri RW; Orozco R; Miller MC; Oesterling JE
J Urol; 1997 Sep; 158(3 Pt 1):687-98. PubMed ID: 9258062
[TBL] [Abstract][Full Text] [Related]
2. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
Tewari A; Narayan P
J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
[TBL] [Abstract][Full Text] [Related]
3. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
Partin AW; Kattan MW; Subong EN; Walsh PC; Wojno KJ; Oesterling JE; Scardino PT; Pearson JD
JAMA; 1997 May; 277(18):1445-51. PubMed ID: 9145716
[TBL] [Abstract][Full Text] [Related]
4. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
[TBL] [Abstract][Full Text] [Related]
5. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
6. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
7. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
[TBL] [Abstract][Full Text] [Related]
9. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC
J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229
[TBL] [Abstract][Full Text] [Related]
10. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
[TBL] [Abstract][Full Text] [Related]
11. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.
Bluestein DL; Bostwick DG; Bergstralh EJ; Oesterling JE
J Urol; 1994 May; 151(5):1315-20. PubMed ID: 7512662
[TBL] [Abstract][Full Text] [Related]
12. Indications for seminal vesicle biopsy and laparoscopic pelvic lymph node dissection in men with localized carcinoma of the prostate.
Stone NN; Stock RG; Unger P
J Urol; 1995 Oct; 154(4):1392-6. PubMed ID: 7658545
[TBL] [Abstract][Full Text] [Related]
13. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
Stone NN; Stock RG
Mt Sinai J Med; 1999 Jan; 66(1):26-30. PubMed ID: 9989102
[TBL] [Abstract][Full Text] [Related]
15. Pelvic lymph node dissection in prostate cancer.
Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
[TBL] [Abstract][Full Text] [Related]
16. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in "high-risk" prostate cancer compared to MRI or CT.
Borley N; Fabrin K; Sriprasad S; Mondaini N; Thompson P; Muir G; Poulsen J
Scand J Urol Nephrol; 2003; 37(5):382-6. PubMed ID: 14594685
[TBL] [Abstract][Full Text] [Related]
18. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen.
Obek C; Louis P; Civantos F; Soloway MS
J Urol; 1999 Feb; 161(2):494-8; discussion 498-9. PubMed ID: 9915434
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
20. Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen.
Polascik TJ; Pearson JD; Partin AW
Semin Urol Oncol; 1998 Aug; 16(3):160-71. PubMed ID: 9741421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
